NGS Manufacturers Market - Core Laboratory Director and Professor of Pathology, U.S. AMC

A practicing pathologist oversees both clinical use of NGS for somatic tumor genotyping and research use of NGS at the genomics core facility of their institution. At both the clinical diagnostic lab and research core they are the key decision maker for instrument selection. They utilize Illumina, Thermo Fisher, and PacBio instruments, and they are actively evaluating Element, Singular, and Ultima instruments. They are familiar with MGI and Oxford Nanopore instruments as well. They view pain points for NGS as library prep and difficulty in fully realizing economies of scale. Their key unmet bioinformatics needs include availability of bioinformaticians, multimodal data integration, and management of variant databases. They were able to respond to questions from both a clinical and non-clinical perspective and discuss each vendor mentioned.

‍